Arterial Spin Labeling May Contribute to the Prediction of Cognitive Deterioration in Healthy Elderly Individuals

References

• 1. Golde TE, Schneider LS, Koo EH. Anti-aβ therapeutics in Alzheimer’s disease: the need for a paradigm shift. Neuron 2011;69(2):203–213.
  MedlineGoogle Scholar
• 2. Lemere CA, Masliah E. Can Alzheimer disease be prevented by amyloid-beta immunotherapy? Nat Rev Neurol 2010;6(2):108–119.
  MedlineGoogle Scholar
• 3. Chételat G, La Joie R, Villain N, et al. Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer’s disease. Neuroimage Clin 2013;2:356–365.
  MedlineGoogle Scholar
• 4. Fox MD, Greicius M. Clinical applications of resting state functional connectivity. Front Syst Neurosci 2010;4:19.
  MedlineGoogle Scholar
• 5. Plant C, Teipel SJ, Oswald A, et al. Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer’s disease. Neuroimage 2010;50(1):162–174.
  MedlineGoogle Scholar
• 6. Misra C, Fan Y, Davatzikos C. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage 2009;44(4):1415–1422.
  MedlineGoogle Scholar
• 7. Fan Y, Batmanghelich N, Clark CM, Davatzikos C; Alzheimer’s Disease Neuroimaging Initiative. Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. Neuroimage 2008;39(4):1731–1743.
  MedlineGoogle Scholar
• 8. Haller S, Nguyen D, Rodriguez C, et al. Individual prediction of cognitive decline in mild cognitive impairment using support vector machine-based analysis of diffusion tensor imaging data. J Alzheimers Dis 2010;22(1):315–327.
  MedlineGoogle Scholar
• 9. Haller S, Missonnier P, Herrmann FR, et al. Individual classification of mild cognitive impairment subtypes by support vector machine analysis of white matter DTI. AJNR Am J Neuroradiol 2013;34(2):283–291.
  MedlineGoogle Scholar
• 10. O’Dwyer L, Lamberton F, Bokde AL, et al. Using support vector machines with multiple indices of diffusion for automated classification of mild cognitive impairment. PLoS ONE 2012;7(2):e32441.
  MedlineGoogle Scholar
• 11. Haller S, Bartsch A, Nguyen D, et al. Cerebral microhemorrhage and iron deposition in mild cognitive impairment: susceptibility-weighted MR imaging assessment. Radiology 2010;257(3):764–773.
  Google Scholar
• 12. Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM. Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology 2009;250(3):856–866.
  Google Scholar
• 13. Yoshiura T, Hiwatashi A, Noguchi T, et al. Arterial spin labelling at 3-T MR imaging for detection of individuals with Alzheimer’s disease. Eur Radiol 2009;19(12):2819–2825.
  MedlineGoogle Scholar
• 14. Yoshiura T, Hiwatashi A, Yamashita K, et al. Simultaneous measurement of arterial transit time, arterial blood volume, and cerebral blood flow using arterial spin-labeling in patients with Alzheimer disease. AJNR Am J Neuroradiol 2009;30(7):1388–1393.
  MedlineGoogle Scholar
• 15. Alsop DC, Detre JA, Grossman M. Assessment of cerebral blood flow in Alzheimer’s disease by spin-labeled magnetic resonance imaging. Ann Neurol 2000;47(1):93–100.
  MedlineGoogle Scholar
• 16. Binnewijzend MA, Kuijer JP, Benedictus MR, et al. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology 2013;267(1):221–230.
  Google Scholar
• 17. Johnson NA, Jahng GH, Weiner MW, et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 2005;234(3):851–859.
  Google Scholar
• 18. Xu G, Rowley HA, Wu G, et al. Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer’s disease. NMR Biomed 2010;23(3):286–293.
  MedlineGoogle Scholar
• 19. Chao LL, Pa J, Duarte A, et al. Patterns of cerebral hypoperfusion in amnestic and dysexecutive MCI. Alzheimer Dis Assoc Disord 2009;23(3):245–252.
  MedlineGoogle Scholar
• 20. Herholz K, Salmon E, Perani D, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002;17(1):302–316.
  MedlineGoogle Scholar
• 21. Du AT, Jahng GH, Hayasaka S, et al. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology 2006;67(7):1215–1220.
  MedlineGoogle Scholar
• 22. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12(3):189–198.
  MedlineGoogle Scholar
• 23. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67(6):361–370.
  MedlineGoogle Scholar
• 24. Barberger-Gateau P, Commenges D, Gagnon M, Letenneur L, Sauvel C, Dartigues JF. Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. J Am Geriatr Soc 1992;40(11):1129–1134.
  MedlineGoogle Scholar
• 25. Wechsler DA. Wechsler Memory Scale. 3rd ed. San Antonio, Tex: Psychological Corporation, 1997.
  Google Scholar
• 26. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8(3):271–276.
  Google Scholar
• 27. Adam S, Van der Linden M, Ivanoiu A, Juillerat AC, Bechet S, Salmon E. Optimization of encoding specificity for the diagnosis of early AD: the RI-48 task. J Clin Exp Neuropsychol 2007;29(5):477–487.
  MedlineGoogle Scholar
• 28. Baddley A, Emslie H, Nimmo-Smith I. A test of visual and verbal recall and recognition. Bury St. Edmunds, England: Thames Valley Test Company, 1994.
  Google Scholar
• 29. Heaton RK. Wisconsin Card Sorting Test manual. Odessa, Fla: Psychological Assessment Resources, 1981.
  Google Scholar
• 30. Cardebat D, Doyon B, Puel M, Goulet P, Joanette Y. Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level [in French]. Acta Neurol Belg 1990;90(4):207–217.
  MedlineGoogle Scholar
• 31. Kaplan EF, Goodglass H, Weintraub S. The Boston naming test. 2nd ed. Philadelphia, Pa: Lea & Febiger, 1983.
  Google Scholar
• 32. Ghent L. Perception of overlapping and embedded figures by children of different ages. Am J Psychol 1956;69(4):575–587.
  MedlineGoogle Scholar
• 33. Schnider A, Hanlon RE, Alexander DN, Benson DF. Ideomotor apraxia: behavioral dimensions and neuroanatomical basis. Brain Lang 1997;58(1):125–136.
  MedlineGoogle Scholar
• 34. Poeck K. Clues to the nature of disruption to limb praxis. In: Roy EA, ed. Neuropsychological studies of apraxia and related disorders. New York, NY: North-Holland, 1985; 99–109.
  Google Scholar
• 35. Welsh KA, Butters N, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). V. A normative study of the neuropsychological battery. Neurology 1994;44(4):609–614.
  MedlineGoogle Scholar
• 36. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140(6):566–572.
  MedlineGoogle Scholar
• 37. Van der Linden M, Coyette F, Poitrenaud J, et al. L’épreuve de rappel libre/rappel indicé à 16 items (RL/RI – 16). In: Van der Linden M, Adam S, Agniel A, et les membres du GREMEM, eds. L’évaluation des troubles de la mémoire. Présentation de quatre tests de mémoire épisodique (avec leur étalonnage). Marseille, France: Solal, 2004; 25–47.
  Google Scholar
• 38. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58(12):1985–1992.
  MedlineGoogle Scholar
• 39. Luh WM, Wong EC, Bandettini PA, Hyde JS. QUIPSS II with thin-slice TI1 periodic saturation: a method for improving accuracy of quantitative perfusion imaging using pulsed arterial spin labeling. Magn Reson Med 1999;41(6):1246–1254.
  MedlineGoogle Scholar
• 40. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 1987;149(2):351–356.
  MedlineGoogle Scholar
• 41. Wang J, Licht DJ, Jahng GH, et al. Pediatric perfusion imaging using pulsed arterial spin labeling. J Magn Reson Imaging 2003;18(4):404–413.
  MedlineGoogle Scholar
• 42. Smith SM, Nichols TE. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 2009;44(1):83–98.
  MedlineGoogle Scholar
• 43. Tomlinson BE, Blessed G, Roth M. Observations on the brains of non-demented old people. J Neurol Sci 1968;7(2):331–356.
  MedlineGoogle Scholar
• 44. Bozoki AC, Korolev IO, Davis NC, Hoisington LA, Berger KL. Disruption of limbic white matter pathways in mild cognitive impairment and Alzheimer’s disease: a DTI/FDG-PET study. Hum Brain Mapp 2012;33(8):1792–1802.
  MedlineGoogle Scholar
• 45. Pagani M, Dessi B, Morbelli S, et al. MCI patients declining and not-declining at mid-term follow-up: FDG-PET findings. Curr Alzheimer Res 2010;7(4):287–294.
  MedlineGoogle Scholar
• 46. Buxton RB, Frank LR. A model for the coupling between cerebral blood flow and oxygen metabolism during neural stimulation. J Cereb Blood Flow Metab 1997;17(1):64–72.
  MedlineGoogle Scholar
• 47. Aubert A, Costalat R. A model of the coupling between brain electrical activity, metabolism, and hemodynamics: application to the interpretation of functional neuroimaging. Neuroimage 2002;17(3):1162–1181.
  MedlineGoogle Scholar
• 48. Choo IH, Lee DY, Oh JS, et al. Posterior cingulate cortex atrophy and regional cingulum disruption in mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging 2010;31(5):772–779.
  MedlineGoogle Scholar
• 49. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc Natl Acad Sci U S A 2001;98(2):676–682.
  MedlineGoogle Scholar
• 50. Beckmann CF, DeLuca M, Devlin JT, Smith SM. Investigations into resting-state connectivity using independent component analysis. Philos Trans R Soc Lond B Biol Sci 2005;360(1457):1001–1013.
  MedlineGoogle Scholar
• 51. Damoiseaux JS, Rombouts SA, Barkhof F, et al. Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci U S A 2006;103(37):13848–13853.
  MedlineGoogle Scholar
• 52. Barkhof F, Haller S, Rombouts SA. Resting-state functional MR imaging: a new window to the brain. Radiology 2014;272(1):29–49.
  Google Scholar
• 53. Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A 2004;101(13):4637–4642.
  MedlineGoogle Scholar
• 54. Sheline YI, Raichle ME. Resting state functional connectivity in preclinical Alzheimer’s disease. Biol Psychiatry 2013;74(5):340–347.
  MedlineGoogle Scholar
• 55. Binnewijzend MA, Schoonheim MM, Sanz-Arigita E, et al. Resting-state fMRI changes in Alzheimer’s disease and mild cognitive impairment. Neurobiol Aging 2012;33(9):2018–2028.
  MedlineGoogle Scholar
• 56. Sorg C, Riedl V, Mühlau M, et al. Selective changes of resting-state networks in individuals at risk for Alzheimer’s disease. Proc Natl Acad Sci U S A 2007;104(47):18760–18765.
  MedlineGoogle Scholar
• 57. Haller S, Lovblad KO. Potential pitfall of reduced cerebral perfusion in clinical resting state functional MR imaging. Radiology 2011;261(2):664–665.
  Google Scholar
• 58. Chao LL, Buckley ST, Kornak J, et al. ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Dis Assoc Disord 2010;24(1):19–27.
  MedlineGoogle Scholar